User: Guest  Login
More Searchfields
Simple search
Sort by:
and:
More ...

Thiele Orberg, E;Fan, H;Tam, A J;Dejea, C M;Destefano Shields, C E;Wu, S;Chung, L;Finard, B B;Wu, X;Fathi, P;Ganguly, S;Fu, J;Pardoll, D M;Sears, C L;Housseau, F
The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis.
Mucosal Immunol
2017
10
2
421-433

More ...

Borchmann, P;Goergen, H;Kobe, C;Lohri, A;Greil, R;Eichenauer, DA;Zijlstra, JM;Markova, J;Meissner, J;Feuring-Buske, M;Hüttmann, A;Dierlamm, J;Soekler, M;Beck, HJ;Willenbacher, W;Ludwig, WD;Pabst, T;Topp, MS;Hitz, F;Bentz, M;Keller, UB;Kühnhardt, D;Ostermann, H;Schmitz, N;Hertenstein, B;Aulitzky, W;Maschmeyer, G;Vieler, T;Eich, H;Baues, C;Stein, H;Fuchs, M;Kuhnert, G;Diehl, V;Dietlein, M;Engert, A
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
2018
390
10114
2790-2802

More ...

Krackhardt, Angela M;Heinrich, Bernhard
[Progress in cancer immunotherapy].
MMW Fortschr Med
2017
159
14
48-53

More ...

Audehm, Stefan;Krackhardt, Angela M
Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation.
Oncology Research and Treatment
2017
40
11
691-696

More ...

Knop, S;Langer, C;Engelhardt, M;Mügge, L-O;Reichle, A;Rösler, W;Bassermann, F;Hertenstein, B;Kunitz, A;Röllig, C;Ostermann, H;Schäfer-Eckart, K;Ringhoffer, M;Günther, A;Junghanss, C;Biersack, H;Schreder, M;Liebert, A;Held, S;Einsele, H;Bargou, R C
Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma.
Leukemia
2017
31
8
1816-1819

More ...

Einsele, H;Knop, S;Vogel, M;Müller, J;Kropff, M;Metzner, B;Langer, C;Sayer, H;Jung, W;Dürk, H A;Salwender, H;Wandt, H;Bassermann, F;Gramatzki, M;Rösler, W;Wolf, H-H;Brugger, W;Engelhardt, M;Fischer, T;Liebisch, P;Straka, C
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.
Leukemia
2017
31
6
1463-1466

More ...

Krönke, J;Kuchenbauer, F;Kull, M;Teleanu, V;Bullinger, L;Bunjes, D;Greiner, A;Kolmus, S;Köpff, S;Schreder, M;Mügge, L-O;Straka, C;Engelhardt, M;Döhner, H;Einsele, H;Bassermann, F;Bargou, R;Knop, S;Langer, C
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM).
Leukemia
2017
31
6
1363-1367

More ...

Schottelius, Margret;Osl, Theresa;Poschenrieder, Andreas;Hoffmann, Frauke;Beykan, Seval;Hänscheid, Heribert;Schirbel, Andreas;Buck, Andreas K;Kropf, Saskia;Schwaiger, Markus;Keller, Ulrich;Lassmann, Michael;Wester, Hans-Jürgen
[Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.
Theranostics
2017
7
9
2350-2362

More ...

Klaeger, Susan;Heinzlmeir, Stephanie;Wilhelm, Mathias;Polzer, Harald;Vick, Binje;Koenig, Paul-Albert;Reinecke, Maria;Ruprecht, Benjamin;Petzoldt, Svenja;Meng, Chen;Zecha, Jana;Reiter, Katrin;Qiao, Huichao;Helm, Dominic;Koch, Heiner;Schoof, Melanie;Canevari, Giulia;Casale, Elena;Depaolini, Stefania Re;Feuchtinger, Annette;Wu, Zhixiang;Schmidt, Tobias;Rueckert, Lars;Becker, Wilhelm;Huenges, Jan;Garz, Anne-Kathrin;Gohlke, Bjoern-Oliver;Zolg, Daniel Paul;Kayser, Gian;Vooder, Tonu;Preissner, Robert;Hahne, Hannes;Tõnisson, Neeme;Kramer, Karl;Götze, Katharina;Bassermann, Florian;Schlegl, Judith;Ehrlich, Hans-Christian;Aiche, Stephan;Walch, Axel;Greif, Philipp A;Schneider, Sabine;Felder, Eduard Rudolf;Ruland, Juergen;Médard, Guillaume;Jeremias, Irmela;Spiekermann, Karsten;Kuster, Bernhard
The target landscape of clinical kinase drugs.
Science
2017
358
6367

More ...

Palau, Anna;Garz, Anne-Kathrin;Diesch, Jeannine;Zwick, Anabel;Malinverni, Roberto;Valero, Vanesa;Lappin, Katrina;Casquero, Raquel;Lennartsson, Andreas;Zuber, Johannes;Navarro, Tomàs;Mills, Ken I;Götze, Katharina S;Buschbeck, Marcus
Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes.
Oncotarget
2017
8
70
115002-115017